{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T20:04:48Z","timestamp":1788033888046,"version":"build-2784847793"},"reference-count":40,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":235,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,8,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Cardiovascular autonomic diabetic neuropathy (CAN) is a serious complication of diabetes. No reliable data on the prevalence of CAN among patients with newly diagnosed type 2 diabetes are available. Therefore, the aim of this study was to estimate the prevalence of CAN among patients with newly diagnosed type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>A cohort of 557 patients with newly diagnosed type 2 diabetes with cardiovascular autonomic test results available was selected. Early and confirmed neuropathy were assessed using a standardized methodology and their prevalences determined. A multivariate logistic regression analysis was modeled to study the factors associated with CAN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>In the entire cohort, the prevalence of confirmed CAN was 1.8%, whereas that of early CAN was 15.3%. Prevalence did not differ between men and women. In the multivariate analyses BMI results were independently and significantly associated with CAN after adjusting for age, sex, hemoglobin A1c, pulse pressure, triglyceride-to-HDL cholesterol ratio, kidney function parameters, and antihypertensive treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>CAN could be detected very early in type 2 diabetes. This study may suggest the importance of performing standardized cardiovascular autonomic tests after diagnosis of type 2 diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc15-0081","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T03:17:10Z","timestamp":1434079030000},"page":"1487-1493","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":64,"title":["Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)"],"prefix":"10.2337","volume":"38","clinical-trial-number":[{"clinical-trial-number":"nct01526720","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01526720","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Giacomo","family":"Zoppini","sequence":"first","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Cacciatori","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Raimondo","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Gemma","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Trombetta","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Dauriz","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Brangani","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Pichiri","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Negri","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Stoico","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Bergamini","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Santi","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Thomaseth","sequence":"additional","affiliation":[{"name":"National Research Council, Institute of Bioengineering, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bellavere","sequence":"additional","affiliation":[{"name":"National Research Council, Institute of Bioengineering, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo C.","family":"Bonadonna","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Bonora","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2015,6,11]]},"reference":[{"key":"2022031221031063200_B1","first-page":"1081","article-title":"Proceedings of a consensus development conference on standardized measures in diabetic neuropathy","volume":"15","author":"Kahn","year":"1992","journal-title":"Diabetes Care"},{"key":"2022031221031063200_B2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jdi.12042","article-title":"Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease","volume":"4","author":"Vinik","year":"2013","journal-title":"J Diabetes Investig"},{"key":"2022031221031063200_B3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0002-9149(00)00920-6","article-title":"Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study)","volume":"86","author":"Singh","year":"2000","journal-title":"Am J Cardiol"},{"key":"2022031221031063200_B4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2009.476","article-title":"Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled study","volume":"301","author":"Young","year":"2009","journal-title":"JAMA"},{"key":"2022031221031063200_B5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0300-595X(86)80078-0","article-title":"Autonomic neuropathy: its diagnosis and prognosis","volume":"15","author":"Ewing","year":"1986","journal-title":"Clin Endocrinol Metab"},{"key":"2022031221031063200_B6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diacare.8.5.491","article-title":"The value of cardiovascular autonomic function tests: 10 years experience in diabetes","volume":"8","author":"Ewing","year":"1985","journal-title":"Diabetes Care"},{"key":"2022031221031063200_B7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/dmrr.1239","article-title":"Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management","volume":"27","author":"Spallone","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031221031063200_B8","first-page":"143","article-title":"Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers","volume":"19","author":"Ziegler","year":"1993","journal-title":"Diabetes Metab"},{"key":"2022031221031063200_B9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0026-0495(03)00095-7","article-title":"Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications\u2014the French multicenter study","volume":"52","author":"Valensi","year":"2003","journal-title":"Metabolism"},{"key":"2022031221031063200_B10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.numecd.2010.07.005","article-title":"Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy","volume":"21","author":"Spallone","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2022031221031063200_B11","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/diacare.17.12.1422","article-title":"Peripheral autonomic impairment in patients newly diagnosed with type II diabetes","volume":"17","author":"McDaid","year":"1994","journal-title":"Diabetes Care"},{"key":"2022031221031063200_B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0891-6632(91)90002-7","article-title":"Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes","volume":"5","author":"Ratzmann","year":"1991","journal-title":"J Diabet Complications"},{"key":"2022031221031063200_B13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2337\/diab.38.10.1307","article-title":"Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects","volume":"38","author":"Lehtinen","year":"1989","journal-title":"Diabetes"},{"key":"2022031221031063200_B14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.diabres.2008.09.054","article-title":"Prevalence and pattern of cardiac autonomic dysfunction in newly detected type 2 diabetes mellitus","volume":"83","author":"Jyotsna","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031221031063200_B15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.diabres.2006.07.027","article-title":"Clinical and electrophysiological correlations in type 2 diabetes mellitus at diagnosis","volume":"76","author":"Rota","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031221031063200_B16","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/dc11-0903","article-title":"Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study","volume":"34","author":"Charles","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031221031063200_B17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"2022031221031063200_B18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1464-5491.2007.02076.x","article-title":"Effect of moderate aerobic exercise on sympatho-vagal balance in Type 2 diabetic patients","volume":"24","author":"Zoppini","year":"2007","journal-title":"Diabet Med"},{"key":"2022031221031063200_B19","first-page":"1470","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology","volume":"46","year":"1998","journal-title":"Neurology"},{"key":"2022031221031063200_B20","first-page":"873","article-title":"Assessment: clinical autonomic testing report of the Therapeutic and Technology Assessment Subcommittee of the America Academy of Neurology","volume-title":"Neurology","year":"1996"},{"key":"2022031221031063200_B21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2337\/diacare.11.7.592","article-title":"Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy","volume":"11","author":"American Diabetes Association American Academy of Neurology","year":"1988","journal-title":"Diabetes Care"},{"key":"2022031221031063200_B22","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1136\/bmj.285.6355.1599","article-title":"Reduced sinus arrhythmia in diabetic autonomic neuropathy: diagnostic value of an age-related normal range","volume":"285","author":"Smith","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2022031221031063200_B23","first-page":"787","article-title":"Valori di normalit\u00e0 dei test cardiovascolari per la diagnosi di neuropatia autonomica diabetica ottenuti con acquisizione computerizzata ed analisi automatica della variazioni di frequenza cardiaca. Atti del XIII Congresso Nazionale SID","volume":"3","author":"Balzani","year":"1991","journal-title":"Diabete"},{"key":"2022031221031063200_B24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.amjmed.2009.07.031","article-title":"Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome","volume":"123","author":"Chang","year":"2010","journal-title":"Am J Med"},{"key":"2022031221031063200_B25","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-2175","article-title":"Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose","volume":"92","author":"Wu","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221031063200_B26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2796.1990.tb00119.x","article-title":"Autonomic neuropathy in non-insulin dependent (type II) diabetes mellitus. Possible influence of obesity","volume":"227","author":"Bergstr\u00f6m","year":"1990","journal-title":"J Intern Med"},{"key":"2022031221031063200_B27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1291\/hypres.23.303","article-title":"Sympathetic activity and body mass index contribute to blood pressure levels","volume":"23","author":"Masuo","year":"2000","journal-title":"Hypertens Res"},{"key":"2022031221031063200_B28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","article-title":"The inflammatory reflex","volume":"420","author":"Tracey","year":"2002","journal-title":"Nature"},{"key":"2022031221031063200_B29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.yjmcc.2011.08.018","article-title":"Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation","volume":"52","author":"Belin de Chantemele","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"2022031221031063200_B30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/HYPERTENSIONAHA.110.168427","article-title":"Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice","volume":"58","author":"Belin de Chantem\u00e8le","year":"2011","journal-title":"Hypertension"},{"key":"2022031221031063200_B31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/HYPERTENSIONAHA.111.171025","article-title":"Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men","volume":"58","author":"Lambert","year":"2011","journal-title":"Hypertension"},{"key":"2022031221031063200_B32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.HYP.31.1.68","article-title":"Baroreflex control of sympathetic nerve activity in essential and secondary hypertension","volume":"31","author":"Grassi","year":"1998","journal-title":"Hypertension"},{"key":"2022031221031063200_B33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdiacomp.2010.06.001","article-title":"The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes","volume":"25","author":"Voulgari","year":"2011","journal-title":"J Diabetes Complications"},{"key":"2022031221031063200_B34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1464-5491.2010.03027.x","article-title":"Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications","volume":"27","author":"Ayad","year":"2010","journal-title":"Diabet Med"},{"key":"2022031221031063200_B35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s001250051344","article-title":"Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study","volume":"43","author":"Gerritsen","year":"2000","journal-title":"Diabetologia"},{"key":"2022031221031063200_B36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-8227(96)01354-X","article-title":"Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes","volume":"34","author":"Spallone","year":"1997","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031221031063200_B37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.17925\/USE.2008.04.2.82","article-title":"Autonomic neuropathy is treatable","volume":"4","author":"Vinik","year":"2008","journal-title":"US Endocrinol"},{"key":"2022031221031063200_B38","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc15-S003","article-title":"American Diabetes Association. Standards of medical care in diabetes\u20142015: summary of revisions","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031221031063200_B39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00125-012-2744-5","article-title":"Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study","volume":"56","author":"Charles","year":"2013","journal-title":"Diabetologia"},{"key":"2022031221031063200_B40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/38\/8\/1487\/625674\/dc150081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/38\/8\/1487\/625674\/dc150081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:08:58Z","timestamp":1647126538000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/38\/8\/1487\/31380\/Prevalence-of-Cardiovascular-Autonomic-Neuropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,11]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,6,11]]},"published-print":{"date-parts":[[2015,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc15-0081","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,11]]}}}